Harvard Bioscience Introduces Next Generation Inhalation System to Aid in the Fight Against COVID-19
23 mars 2020 09h00 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 23, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) has launched an innovative technology – known as Accumulated Inhaled Aerosol (AIA) – for academic...
CORRECTION – Harvard Bioscience Announces Fourth Quarter 2019 Financial Results
26 févr. 2020 12h24 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline issued earlier today by Harvard Bioscience, Inc. (Nasdaq: HBIO), please note that the table titled...
Harvard Bioscience Announces Fourth Quarter 2019 Financial Results
26 févr. 2020 07h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and twelve months ended December 31, 2019....
Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET
11 févr. 2020 17h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2019 before the market opens on...
Harvard Bioscience to attend Benchmark’s 8th Annual Discovery One-on-One Conference
21 nov. 2019 16h45 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will attend The...
Harvard Bioscience Announces Third Quarter Financial Results
05 nov. 2019 16h00 HE
|
Harvard Bioscience, Inc.
Improves adjusted operating margins while taking actions to underpin next year’s profit and growth targets Q3 Revenue of $27.4 millionQ3 Operating Loss (GAAP) of $(1.4) million; Adjusted Operating...
Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 nov. 2019 08h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Yash Singh being named Executive Vice President, Cellular &...
Harvard Bioscience Announces Executive Appointment
31 oct. 2019 17h10 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Yash Singh has been named Executive Vice President, Cellular & Molecular...
Harvard Bioscience Schedules Third Quarter 2019 Earnings Conference Call for November 5 at 4:30 PM ET
22 oct. 2019 18h31 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for third quarter ended September 30, 2019 after market close on...
Harvard Bioscience Announces Executive Appointment
21 oct. 2019 08h45 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Ken Olson has been named Vice President and General Manager, Pre-Clinical Systems...